ArticleCureus2026
Trends in Premature Mortality Due to Alcoholic Cardiomyopathy Among Working Adults Aged 25-64 Years in the United States, 1999-2024: A CDC Wide-Ranging Online Data for Epidemiologic Research (WONDER) Analysis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Alcoholic cardiomyopathy (ACM) is an important alcohol-related cardiovascular condition associated with heart failure and premature mortality. However, long-term national trends in ACM mortality among working-age adults and changes during the COVID-19 pandemic remain incompletely characterized. Methods We conducted a retrospective population-based analysis of United States (US) mortality data from the Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research (CDC WONDER) database. Deaths with ACM (International Classification of Diseases, Tenth Revision [ICD-10] code I42.6) as the underlying cause of death were identified for 1999-2024. Adults aged 25-64 years were considered the working-age population. Crude mortality rates (CMRs) and age-adjusted mortality rates (AAMRs) were calculated per 1,000,000 population, with analyses stratified by sex, ethnicity (Hispanic origin), and age subgroup. Results Between 1999 and 2024, there were 13,741 deaths attributed to ACM, including 9,705 (70.63%) among adults aged 25-64 years. The pooled premature CMR was 2.3 per 1,000,000 population (95% CI: 2.2-2.3). Men accounted for 85.24% of premature deaths, with a pooled CMR of 3.9 per 1,000,000 compared with 0.7 per 1,000,000 among women. Adults aged 45-64 years accounted for 78.79% of premature deaths and had a CMR of 3.8 per 1,000,000 compared with 0.9 per 1,000,000 among those aged 25-44 years. Mortality increased during 2020-2021, reaching a peak in 2021, followed by a progressive decline through 2024. In 2024, the premature CMR was 1.9 per 1,000,000. AAMRs largely followed CMR trends. Conclusion ACM accounted for a substantial proportion of premature alcohol-related cardiovascular mortality in working-age adults in the US. Mortality was disproportionately concentrated among men and adults aged 45-64 years, increased during 2020-2021, and subsequently declined. These findings highlight persistent disparities and the need for continued prevention, early recognition, and targeted reduction of alcohol-related cardiovascular risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.